stocks
THYROCARE

Thyrocare Technologies Ltd.

555.60-1.6 (-0.29%)
3 Jul, 3:30 PM

Stock Scores

Quality Score

99.4 / 100

Value Score

16.0 / 100

Price Momentum Score

93.7 / 100

QVM Score

88.1 / 100

Key Metrics

Market Cap
8868.67
P/E (TTM)
54.40
P/B
15.15
P/S (TTM)
10.70
EV/EBITDA
33.19
CAPE (5Y)
78.33
ROE (TTM)
28.80
ROCE (TTM)
33.67
ROA (TTM)
22.64
Avg 3Y ROE
19.73
Earnings 3Y CAGR
36.17
Sales 3Y CAGR
16.33
Sales 5Y CAGR
10.88
Debt/Equity
0.09
Consensus TP
600.00
Strong Buy %
60.00
Promoter Holding
60.92
Pledged %
100.00

Share Price

Track Thyrocare Technologies Ltd.'s current share price, historical price chart, 52-week high/low, and performance across different time periods.

1 Week returns: 7.42 %
Low
515.4
High
565.0
1 Month returns: 5.79 %
Low
495.0
High
578.3
1 Year returns: 64.18 %
Low
334.4
High
578.3
3 Year CAGR: 47.21 %
Low
168.9
High
578.3
5 Year CAGR: 4.68 %
Low
138.5
High
578.3
Note: Prices may be delayed by a few minutes. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.

Financial Snapshot

See detailed analysis

Multi-year trends for Thyrocare Technologies Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Thyrocare Technologies Ltd. Shareholding Pattern

Quarterly breakdown of Thyrocare Technologies Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Thyrocare Technologies Ltd. shares as reported to NSE and BSE.

Frequently Asked Questions

What is the current share price of Thyrocare Technologies Ltd.?
The current share price of Thyrocare Technologies Ltd. is ₹ 555.60 as of 3 Jul 2026.
What is the market capitalisation of Thyrocare Technologies Ltd.?
The market capitalisation of Thyrocare Technologies Ltd. stands at ₹ 8,868.67 Cr.
What is the PE ratio of Thyrocare Technologies Ltd.?
The Price-to-Earnings (PE) ratio of Thyrocare Technologies Ltd. is 54.40 as of the latest trailing twelve months data.
What is the ROE and ROCE of Thyrocare Technologies Ltd.?
Thyrocare Technologies Ltd. has a Return on Equity (ROE) of 28.80% and a Return on Capital Employed (ROCE) of 33.67% as per the latest financial reports.
What is the 52-week high and low of Thyrocare Technologies Ltd.?
The 52-week high of Thyrocare Technologies Ltd. is - and the 52-week low is -.
What is the dividend yield of Thyrocare Technologies Ltd.?
The dividend yield of Thyrocare Technologies Ltd. is 1.68% based on the current market price.
What is the FII and DII holding in Thyrocare Technologies Ltd.?
Foreign Institutional Investors (FII) hold 5.37%, Domestic Institutional Investors (DII) hold 19.82% and retail/public investors hold 11.60% of Thyrocare Technologies Ltd. shares.
What sector does Thyrocare Technologies Ltd. belong to?
Thyrocare Technologies Ltd. operates in the Healthcare sector. 100% of analysts have a Buy or Strong Buy rating on Thyrocare Technologies Ltd. with a consensus target price of ₹ 600.00, implying 7.68% upside from current levels.
What is the beta of Thyrocare Technologies Ltd.?
The beta of Thyrocare Technologies Ltd. is 0.56, indicating its price volatility relative to the broader market. Over the past 1 year, Thyrocare Technologies Ltd. has delivered an absolute return of 74.74%.
What is the RSI of Thyrocare Technologies Ltd.?
The 14-day Relative Strength Index (RSI) of Thyrocare Technologies Ltd. is 62.19, placing it approaching overbought territory. An RSI above 70 is considered overbought and below 30 is considered oversold.